Sharma M, Jagirdhar GSK, Guntupalli KK, Kashyap R, Surani S. Heart failure in general and cardiac transplant patients with COVID-19. World J Cardiol 2022; 14(7): 392-402 [PMID: 36161057 DOI: 10.4330/wjc.v14.i7.392]
Corresponding Author of This Article
Salim Surani, FACP, FCCP, MD, MSc, Doctor, Professor, Department of Medicine, Texas A&M University, 8441 Riverside Pkwy, Bryan, TX 77807, United States. srsurani@hotmail.com
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Jul 26, 2022; 14(7): 392-402 Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.392
Heart failure in general and cardiac transplant patients with COVID-19
Munish Sharma, Gowthami Sai Kogilathota Jagirdhar, Kalpalatha K Guntupalli, Rahul Kashyap, Salim Surani
Munish Sharma, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, United States
Gowthami Sai Kogilathota Jagirdhar, Department of Medicine, St Michaels' Medical Center, Newark, NJ 07102, United States
Kalpalatha K Guntupalli, Department of Pulmonary, Critical Care and Sleep, Baylor College of Medicine, Houston, TX 77030, United States
Rahul Kashyap, Salim Surani, Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, United States
Salim Surani, Department of Medicine, Texas A&M University, Bryan, TX 77807, United States
Author contributions: Sharma M and Jagirdhar G did the literature search and manuscript preparation; Kashyap R, Guntupalli K and Surani S contributed in write-upkeep, editing, and revision of the manuscript.
Conflict-of-interest statement: None of the authors have any conflict of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Salim Surani, FACP, FCCP, MD, MSc, Doctor, Professor, Department of Medicine, Texas A&M University, 8441 Riverside Pkwy, Bryan, TX 77807, United States. srsurani@hotmail.com
Received: February 25, 2022 Peer-review started: February 25, 2022 First decision: April 8, 2022 Revised: April 19, 2022 Accepted: June 24, 2022 Article in press: June 24, 2022 Published online: July 26, 2022 Processing time: 144 Days and 23.5 Hours
Abstract
Coronavirus disease 2019 (COVID-19) is primarily an infection of the respiratory tract, but it can have multisystem manifestations. Cardiac complications of COVID-19 can range from acute myocardial injury, cardiac arrhythmias, or heart failure, amongst others. Heart failure (HF) in COVID-19 can be a de novo process or due to worsening of pre-existing cardiovascular ailment. HF in a patient with COVID-19 not only poses challenges in clinical presentation and management of COVID-19 but also affect prognosis of the patient. This article aims to succinctly revisit the implications of this pandemic regarding pre-existing HF or new-onset HF based on prevailing data. It also focuses on the management and special recommendations from prior studies and guidelines.
Core Tip: The mini-review is composed of assimilation of guidelines and current literature recommendations for managing heart failure in coronavirus disease 2019 (COVID-19) patients. We discuss many important aspects of heart-failure in COVID-19 from epidemiology to post recovery rehabilitation.
